Bio-Techne Corporation (NASDAQ:TECH) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2023.
Bio-Techne Corp (TECH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Select Equity Group Robert Joseph Caruso | 7,153,947 | $592,919,127 | +383% | 2.22% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,108,443 | $91,867,756 | +91% | 0.2% |
| 3. | Montanaro Asset Management Charles Montanaro | 387,800 | $32,140,864 | +281% | 5.23% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 226,968 | $18,811,108 | +218% | 0.05% |
| 5. | Sandler Capital Management Andrew Sandler | 171,280 | $14,195,686 | +724% | 1.45% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $352.55 | 300 | 10,106 | 2022-05-10 | Filing | ||
| $185.00 | 100 | Officer, Director | 100 | 2019-09-09 | Filing | |
| $185.00 | 100 | Officer, Director | 100 | 2019-09-09 | Filing | |
| $191.06 | 500 | Director | 8,726 | 2019-08-07 | Filing | |
| $65.00 | 2,361 | Director | 70,000 | 2013-05-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $82.12 | 7,450 | 26,092 | 2022-12-08 | Filing | ||
| $82.01 | 800 | 26,092 | 2022-12-07 | Filing | ||
| $380.71 | 8 | Director | 5,502 | 2022-08-11 | Filing | |
| $385.47 | 504 | Director | 5,510 | 2022-08-11 | Filing | |
| $380.15 | 992 | Director | 6,014 | 2022-08-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 18,199,432 | $1,508,368,924 | 0.04% | |
| 2. | 15,888,640 | $1,316,850,492 | 0.04% | |
| 3. | 6,351,230 | $526,389,942 | 0.03% | |
| 4. | 5,519,062 | $457,419,859 | 1.53% | |
| 5. | 4,134,391 | $342,658,326 | 0.33% |
News See All
Do You Think Bio-Techne Corporation (TECH) Has a Positive Long-Term Trend?
Jackson Square Partners, an investment management firm, released its “SMID-Cap Growth” Q3 2022 investor letter. A copy of the same can be downloaded here.
Should You Invest in Bio-Techne Corporation (TECH)?
Conestoga Capital Advisors, an asset management company, released its “Conestoga Mid Cap Growth Fund” third-quarter investor letter. A copy of the same can be downloaded here.
Should You Invest in Bio-Techne Corporation (TECH)?
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third quarter 2022 investor letter. A copy of the same can be downloaded here.
Can Bio-Techne Corporation (TECH) Still Bounce Back?
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here.
Baron Funds: "Bio-Techne (TECH) is a Stable Business"
Baron Funds, an asset management firm, published its “Baron Health Care Fund” second quarter 2022 investor letter – a copy of which can be downloaded here.
Baron Funds: "Bio-Techne (TECH) Can Still Generate Strong Revenue Growth"
Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2022 investor letter – a copy of which can be downloaded here.
Is it a Wise Decision to Keep Your Bio-Techne (TECH) Position?
Aristotle Capital Management, an independent/employee-owned investment management organization, published its “Aristotle Core Equity” first quarter 2022 investor letter – a copy of which can be ...
Did The Smart Money Get Bio-Techne Corporation (TECH) Right?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
10 Stocks Drawing Attention on Earnings Reports
In this article, we will take a look at the 10 stocks drawing attention on earnings reports.
Billionaire Hedge Funds
